A Biobehavioral Intervention for Young Men With Testicular Cancer

ClinicalTrials.gov ID: NCT04150848

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04150848. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Biobehavioral Intervention for Young Men With Testicular Cancer: A Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a randomized controlled biobehavioral pilot trial designed to investigate the feasibility and preliminary efficacy of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Therapy (ISP) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1) and twelve weeks after intervention at T2. Additionally, identified biomarkers will be measured at baseline and at T2.

Study identification

NCT ID: NCT04150848
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: University of California, Irvine; Other
Enrollment: 100 participants

Conditions and interventions

Conditions

Testis Cancer

Interventions

Goal-Focused Emotion Regulation Therapy (GET) Behavioral
Individual Supportive Psychotherapy (ISP) Behavioral

Behavioral

Eligibility (public fields only)

Age range: 18 Years to 39 Years
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 1, 2018 (Actual)
Primary completion: Nov 2021 (Estimated)
Completion: Dec 2021 (Estimated)
Last update posted: Dec 19, 2020

2018 – 2021

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
University of California, Irvine	Irvine	California	92697-3957	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10017	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04150848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 19, 2020 · Synced Nov 15, 2026